MI-based PrEP Intervention
A Brief Motivational Interviewing-based Intervention to Improve HIV Pre-exposure Prophylaxis Uptake Among Men Who Have Sex With Men
1 other identifier
interventional
86
1 country
1
Brief Summary
Gay, bisexual and other men who have sex with men (MSM) are the group at highest risk of HIV infection in the United States. Pre-exposure prophylaxis (PrEP) has demonstrated high efficacy in preventing HIV infection among MSM. However, uptake in clinical settings has been slow for several reasons, including low awareness and education, low perceived HIV risk, concern for side-effects, and stigma associated with taking the medication. The purpose of the proposed study is to develop and evaluate a brief motivational interviewing (MI) intervention to promote PrEP uptake among MSM during the course of routine HIV screening at a public sexually transmitted disease (STD) clinic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 13, 2017
CompletedFirst Posted
Study publicly available on registry
October 18, 2017
CompletedStudy Start
First participant enrolled
January 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2020
CompletedAugust 25, 2021
March 1, 2019
1.3 years
October 13, 2017
August 24, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
PrEP uptake
Three months
Study Arms (2)
Intervention
EXPERIMENTALStandard-of-care
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- years of age or older
- Assigned male at birth and currently identify as male
- Score at least 10 on the HIV Incident Risk Index for MSM
- HIV-negative based on results of antibody test
- English- or Spanish-speaking
- Have access to a working phone
- Have not taken PrEP
You may not qualify if:
- Have previously taken PrEP
- Symptoms of acute HIV infection at baseline
- HIV positive
- A clinical contraindication to PrEP (e.g., renal dysfunction)
- Non-English or non-Spanish speaking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Miriam Hospital
Providence, Rhode Island, 02906, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Philip A Chan, MD
Brown University/The Miriam Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 13, 2017
First Posted
October 18, 2017
Study Start
January 10, 2019
Primary Completion
April 30, 2020
Study Completion
April 30, 2020
Last Updated
August 25, 2021
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share